⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RGNX News
REGENXBIO Inc.
RGNX Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in REGENXBIO Inc. Securities Lawsuit — The Gross Law Firm
globenewswire.com
RGNX
全球投資者法律顧問 ROSEN 鼓勵 REGENXBIO, Inc. 的投資者在對 RGNX 提出證券集體訴訟的重要截止日期前聘請律師
globenewswire.com
RGNX
RGNX UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026
prnewswire.com
RGNX
RGNX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of REGENXBIO Inc. to Contact the Firm Today!
accessnewswire.com
RGNX
Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of REGENXBIO Inc. – RGNX
accessnewswire.com
RGNX
RGNX Investors Have Opportunity to Lead REGENXBIO, Inc. Securities Fraud Lawsuit
prnewswire.com
RGNX
RGNX EQUITY ALERT: Faruqi & Faruqi, LLP Reminds REGENXBIO (RGNX) Investors of Securities Class Action Deadline on April 14, 2026 Ready to Announce with Confidence?
newsfilecorp.com
RGNX
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages REGENXBIO, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGNX
globenewswire.com
RGNX
Bronstein, Gewirtz & Grossman LLC Urges REGENXBIO Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
RGNX
Gene Therapies in Ophthalmology Market Competitive Landscape Report 2026: Comprehensive Insights About 55+ Companies and 125+ Drugs by Product Type, Stage, Route of Administration, and Molecule Type
globenewswire.com
RGNX